DINGGUI
LIVE

Serial Number

79400932

Owner

YABAO PHARMACEUTICAL GROUP CO., LTD.

Attorney

He Li

Filing Date

Jan 25, 2024

Add to watchlist:

No watchlists yet
View on USPTO

DINGGUI Trademark

Serial Number: 79400932 • Registration: 7797649

DINGGUI is a trademark filed by YABAO PHARMACEUTICAL GROUP CO., LTD. on January 25, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

YABAO PHARMACEUTICAL GROUP CO., LTD. (5 trademarks)

NO. 43 FUMIN ROAD,

Entity Type: 99

Trademark Details

Filing Date

January 25, 2024

Registration Date

May 20, 2025

Published for Opposition

April 1, 2025

Goods & Services

Preparations for the treatment of asthma; medical preparations and drugs for the treatment of respiratory system diseases and disorders; medicated lip balm; decoctions for pharmaceutical purposes for the treatment of respiratory system diseases and disorders; medicinal formulations for skin wounds, namely, pharmaceutical preparations for skin wounds; medicinal formulations for treating bone fractures, namely, pharmaceutical preparations for the treatment of bone fractures; paracetamol; anti-inflammatories; antidiarrheal medicines; pharmaceutical preparations for treating asthma; anti-allergy medications; antiviral preparations; pharmaceuticals for treating viral diseases; pharmaceutical preparations for treating allergies; bulk medicine used for treating cardiovascular and cerebrovascular diseases; vitamin supplement tablets; cough suppressant and phlegm relievers, namely, cough treatment preparations; injectable medications for allergic reactions; mosquito repellent patch for babies; medicated baby powder; fever reducer, namely, ibuprofen; antiemetic drugs, namely, nausea treatment preparations; cough suppressants, namely, cough expectorants; mosquito repellents for use on the skin; preparations for the treatment of heatstroke; anti-inflammatory spray; traditional Chinese medicinal herb preparations; cough drops; pain relief medications; chemotherapeutic drugs, namely, pharmaceutical preparations for use in chemotherapy; antibiotic for humans; medicated ointment for the treatment of dermatological conditions; ointment for treatment of skin diseases; medicated baby oil; ophthalmic pharmaceutical preparations; migraine treatment preparations; balsamic preparations for medical purposes; cough syrup for medical use; dermatological pharmaceuticals; anti-inflammatory preparations; expectorants; pharmaceutical preparations in the form of tablets for treating cardiovascular and cerebrovascular diseases; disinfectants; fever and pain relievers, namely, ibuprofen; anticoagulants; anti-inflammatory ointments; oral ibuprofen for pain relief; injectable pharmaceutical preparations for treating cardiovascular and cerebrovascular diseases; injectable dermal fillers; powdered milk for babies; lutein dietary supplements; dietetic foods adapted for medical use; medicated candies; lecithin dietary supplements; mineral dietary supplements; dietetic beverages adapted for medical use; dietetic foods adapted for medical purposes; baby cookies, namely, baby food; zinc dietary supplement; infant formula; lacteal flour for babies; dietetic beverages adapted for medical purposes; nutritional supplements; candy for pharmaceutical purpose for the treatment of respiratory system diseases and disorders; food for babies; milk sugar for pharmaceutical purposes; dietetic candies adapted for medical purposes; vitamin beverages adapted for medical purposes; casein dietary supplements; liquid formula for infants; linseed oil dietary supplements; protein dietary supplements; disposable baby diapers; baby swim diapers; diaper changing mats, disposable, for babies; disposable swim diapers for toddlers and infants; swim diapers, disposable, for babies; bandages for dressings; medical dressing; adhesive plasters for medical purposes; swim diapers, reusable, for babies

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 8, 2026 FINO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 8, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 24, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 24, 2025 OPNR
FINAL DISPOSITION NOTICE SENT TO IB
Dec 19, 2025 FICS
FINAL DISPOSITION PROCESSED
Dec 19, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 20, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 20, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 20, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 1, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 1, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 26, 2025 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 7, 2025 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 7, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 21, 2025 XAEC
ASSIGNED TO LIE
Feb 21, 2025 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 21, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 21, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 21, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 20, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 20, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 20, 2025 TROA
REFUSAL PROCESSED BY IB
Sep 15, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 26, 2024 RFCS
REFUSAL PROCESSED BY MPU
Aug 26, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 21, 2024 RFCR
NON-FINAL ACTION WRITTEN
Aug 20, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 20, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 31, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 31, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 25, 2024 REPR